Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide in Laparoscopic Hepatectomy
NCT06085976Phase 2Unknown
- Sponsor
- Universidad de Navarra
- Start
- Aug 2023
- Primary completion
- Aug 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of octreotide in hepatocellular carcinoma (HCC), liver metastases, sponsored by Universidad de Navarra. Status: unknown.
02
Drugs
octreotide
03
Conditions
hepatocellular carcinoma (HCC)liver metastases
Beyond the preview
Go deeper on NCT06085976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06085976.